about
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.Comparative performance of oral midazolam clearance and plasma 4β-hydroxycholesterol to explain interindividual variability in tacrolimus clearance.Tubulointerstitial expression and urinary excretion of connective tissue growth factor 3 months after renal transplantation predict interstitial fibrosis and tubular atrophy at 5 years in a retrospective cohort analysis.Predictive Modeling of Tacrolimus Dose Requirements: "All That Is Gold Does Not Glitter".Response to: 'Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'.Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.Kuypers and Vanhove reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and TuckerHigh Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients
P50
Q40322487-3170CE86-3997-42F9-B900-BA3BDDEBFF3BQ47400761-C4DF0D77-BC9A-418C-A6EC-7AF03EC28C3FQ47799865-819792C2-073A-422C-AF9D-DCEABFCA24F8Q48217119-13EBB46D-063D-4395-AB98-47FC3A3A504EQ48268449-8F231F82-EABD-468A-8C16-EF598C6E8108Q48295034-77189FBE-271A-4509-A92D-741356F1E083Q88464210-D6662E2D-49C9-4A04-9DE9-7AC691CC226EQ89058565-FC5C8481-D76D-4577-836D-9A6A59B0E5FB
P50
description
researcher
@en
wetenschapper
@nl
name
Thomas Vanhove
@en
Thomas Vanhove
@nl
type
label
Thomas Vanhove
@en
Thomas Vanhove
@nl
prefLabel
Thomas Vanhove
@en
Thomas Vanhove
@nl
P31
P496
0000-0001-5712-6294